Fosrenol
Drug - Fosrenol (lanthanum)
May 2010
Therapeutic area - Phosphate binders for chronic kidney disease
Criteria
- Patients who have been stabilized on a combination of Fosrenol and calcium acetate after unsuccessful trials of calcium as a single agent will be issued a PA to continue Fosrenol therapy OR
- Patient has a diagnosis of Stage 3-5 Chronic Kidney Disease (CKD) AND
- Has tried calcium acetate consistently
- Has tried Renagel or Renvela consistently
- Has not had adequate serum calcium lowering
Questions?
MHCP Provider Call Center 651-431-2700 or 800-366-5411